149 related articles for article (PubMed ID: 12615412)
1. Cell interaction studies of PLA-MePEG nanoparticles.
Nguyen CA; Allémann E; Schwach G; Doelker E; Gurny R
Int J Pharm; 2003 Mar; 254(1):69-72. PubMed ID: 12615412
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers.
Kim SY; Shin IG; Lee YM
J Control Release; 1998 Dec; 56(1-3):197-208. PubMed ID: 9801443
[TBL] [Abstract][Full Text] [Related]
3. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
Bazile D; Prud'homme C; Bassoullet MT; Marlard M; Spenlehauer G; Veillard M
J Pharm Sci; 1995 Apr; 84(4):493-8. PubMed ID: 7629743
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
[TBL] [Abstract][Full Text] [Related]
5. Methoxy poly(ethylene glycol)-block-poly(delta-valerolactone) copolymer micelles for formulation of hydrophobic drugs.
Lee H; Zeng F; Dunne M; Allen C
Biomacromolecules; 2005; 6(6):3119-28. PubMed ID: 16283736
[TBL] [Abstract][Full Text] [Related]
6. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of six-arm star poly(delta-valerolactone)-block-methoxy poly(ethylene glycol) copolymers.
Zeng F; Lee H; Chidiac M; Allen C
Biomacromolecules; 2005; 6(4):2140-9. PubMed ID: 16004456
[TBL] [Abstract][Full Text] [Related]
8. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
10. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
[TBL] [Abstract][Full Text] [Related]
11. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
12. Aggregation behavior of self-assembling polylactide/poly(ethylene glycol) micelles for sustained drug delivery.
Yang L; Qi X; Liu P; El Ghzaoui A; Li S
Int J Pharm; 2010 Jul; 394(1-2):43-9. PubMed ID: 20434530
[TBL] [Abstract][Full Text] [Related]
13. Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro.
Zheng X; Kan B; Gou M; Fu S; Zhang J; Men K; Chen L; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
Int J Pharm; 2010 Feb; 386(1-2):262-7. PubMed ID: 19932160
[TBL] [Abstract][Full Text] [Related]
14. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
15. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
17. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
18. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
Hu Y; Xie J; Tong YW; Wang CH
J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity of brefeldin A conjugated monomethoxy-poly(ethylene glycol)-b-poly(L-lactide) polymeric micelles.
Liu W; Wei J; Huo P; Lu Y; Chen Y; Wei Y
J Biomater Sci Polym Ed; 2013; 24(8):986-98. PubMed ID: 23647253
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
